Search

Your search keyword '"Rantala, Johanna"' showing total 416 results

Search Constraints

Start Over You searched for: Author "Rantala, Johanna" Remove constraint Author: "Rantala, Johanna"
416 results on '"Rantala, Johanna"'

Search Results

1. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

2. Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium

3. PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants

4. Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants

5. The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.

6. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

7. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

8. PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1

9. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

10. Bakgrundshalter, lakbarhet och markekologisk risk i lerjord : En undersökning av kobolt och nickel i Mälardalen samt arsenik och kobolt i Västra Götaland

11. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

12. An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers

13. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

14. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

15. Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk

16. Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.

17. Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

18. DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.

19. Supplementary Table 2 from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

20. Supplementary Table 3 from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

21. Supplementary Tables 1-9 from Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

22. Data from Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

23. Supplementary Methods, Tables 1-3, Figure 1 from Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

24. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2.

25. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

26. Additional file 3 of Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium

27. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

28. Additional file 1 of Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium

29. Additional file 5 of Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium

30. Additional file 2 of Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium

31. Additional file 4 of Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium

32. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

33. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

34. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

35. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

36. Cirkulära metallflöden i medicinteknisk utrustning

37. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

38. Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study

39. The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

40. Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study

41. Author Correction : A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

43. The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers

44. Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

45. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

46. Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status

47. Additional file 8 of Exploring the link between MORF4L1 and risk of breast cancer

48. Additional file 7 of Exploring the link between MORF4L1 and risk of breast cancer

49. Additional file 16 of Exploring the link between MORF4L1 and risk of breast cancer

50. Additional file 5 of Exploring the link between MORF4L1 and risk of breast cancer

Catalog

Books, media, physical & digital resources